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Tricyclic antidepressant drugs (TCADs)
belong to the first generation of psychotropic drugs
which are still used for treatment of depression and
other mental disorders. These drugs are efficacious
but they are also dangerous with regard to their nar-
row therapeutic window.
In biological material (plasma, serum, urine or
hair), TCADs are mainly determined by chromato-
graphic methods such as gas (1ñ3) or liquid (4ñ6)
chromatography. For the last decade of the 20th cen-
tury, capillary electrophoresis (CE) has been play-
ing a significant role in the drug analysis field.
However, generally, CE technique with the most
commonly used spectrophotometric detection,
shows relatively low sensitivity. It is caused by a
short optical path, as well as by injection of very
small sample volumes (i.e., nanoliters). Several
approaches have been taken in order to solve this
problem such as: modification of optical cell shapes
(7), application of high sensitive detectors (laser
induced fluorescence detector (8), mass spectrome-
try detector (9) or electrochemical detector (10)),
using effective on- and off-line preconcentration
procedures, as well as analyte stacking techniques
in the capillary (11). The last approach of lowering
the analyte detection limit is especially convenient
and suitable for the capillary electrophoresis tech-
nique. Under stacking conditions, a larger sample
volume (5ñ50% of total capillary volume) may be
injected into the capillary without disrupting peaks
and loosing their resolution (12). The possibility of
analyte stacking and other advantages of CE tech-
nique, such as high separation potential and small
sample and reagents consumption, makes CE nowa-
days interesting tool for drug analysis in biological
samples. 
Generally, there is relatively a small number of
CE procedures for determination of TCADs in bio-
logical fluids employing preconcentration of these
drugs in the capillary with the universal UV spec-
trophotometry detection (13, 14). Chen et al. (13)
proposed a sensitive CE method for determination
of two tricyclic antidepressants: amitriptyline and its
metabolite nortriptyline in human plasma using
field-amplified sample stacking (FASS). Extracts of
plasma samples (1 mL) were reconstituted with
water and then electrokinetically injected (3 kV,
99.9 s) into a capillary after insertion of a 6 s water
plug at pressure 10 psi. Detection of the drugs was
2.0 ng/mL for both amitriptyline and nortriptyline.
The sensitive stacking-based CE method for the
analysis of eight tricyclic antidepressants in human
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Figure 1. Chemical structures of the examined tricyclic antidepressant drugs: a. amitriptyline (Ami), b. nortriptyline (Nort), c. imipramine
(Imi), d. desipramine (Des), e. doxepin (Dox), f. nordoxepin (Nordox) and g. clomipramine (IS)
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serum has also been described (14). Stacking was
caused by use of acetonitrile in the presence of sodi-
um chloride as a sample medium. For analysis, 400
µL of spiked serum sample was mixed with acetoni-
trile (600 µL) and sodium chloride, and then cen-
trifuged. The supernatant was introduced in the CE
system. Using a bubble-shaped capillary, the limits
of detection were in the order of 5 ng/nL.
This paper focuses on development of a simple
CE method for screening analysis of six tricyclic
antidepressants: amitriptyline, nortriptyline,
imipramine, desipramine, doxepin, and nordoxepin
(Fig. 1) in human serum. For experimental condi-
tions, the capillary zone electrophoresis (CZE) tech-
nique was chosen and the sample was stacked by
injecting it into the capillary by hydrodynamic or
electrokinetic mode, in an organic (acetonitrile) or
water-organic (0.01% H3PO4-methanol) medium. In
order to find the optimal composition of the back-
ground electrolyte, a 32 factorial design was used. A
three point standard addition method was applied for
calibration of the proposed analytical procedure.
This approach was found to be effective for simulta-
neous reduction of sample volume and time con-
sumption. 
EXPERIMENTAL
Examined drugs and materials
Stock drug solutions of: amitriptyline, nor-
triptyline, imipramine, desipramine, doxepin, nor-
doxepin and clomipramine (IS) in methanol (1
mg/mL) were used for examination. All standard
drugs were purchased from Sigma-Aldrich (St.
Louis, USA). Spiking solutions were prepared by
appropriate dilution of these stock solutions with
water. Drug-free serum (control serum) was
obtained from the blood bank in KrakÛw, Poland.
Reference human serum (Medidrugô TCA S,
MEDICHEM, Steinenbronn, Germany) containing
six examined tricyclic antidepressants was supplied
by Promochem (£omianki, Poland).
Reagents
CAPSO (3-[cyclohexylamino]-2-hydroxy-1-
propanesulfonic acid) (Sigma Ultra) was purchased
from Sigma-Aldrich (Stainheim, Germany).
Methanol (HPLC gradient grade) was supplied by
Merck (Darmstadt, Germany). Sodium hydroxide
and potassium chloride, both of analytical grade,
were obtained from POCh (Gliwice, Poland).
Deionized water was used throughout.
Apparatus
The Prince 550 air thermostated capillary elec-
trophoresis system (Prince Technologies, Emmen,
The Netherlands) was used with a Lambda 1010
spectrophotometer (Bischoff, Leonberg, Germany)
as a detector. Electrophoretic separation was con-
ducted at 30 kV in a bare fused silica capillary of 50
µm i.d and 375 µm o.d. (Polymicro Technologies,
Phoenix, USA), 100 cm long (66 cm to the detector).
Drugs were detected by UV-light absorption at 210
nm. The initial background electrolyte was prepared
by dissolving CAPSO (50 mM) in mixture of
methanol/water (3:7, v/v), adjusted to pH 9.54 with
5 M NaOH. This mixture was then modified during
optimization of the experimental conditions.
Table 1. Enhancement factors of the examined tricyclic antidepressants obtained in CE analysis under the stacking conditions. 
Enhancement factorsa
Sample injection
Drug Hydrodynamic mode Electrokinetic mode
Sample medium
CH3CN  0.01% H3PO4/MeOH  CH3CN  0.01 % H3PO4/MeOH
Amitriptyline 3.9 5.4 4.1 3.7
Nortiptyline 3.3 6.0 6.0 3.4
Imipramine 3.3 5.8 4.0 3.4
Desipramine 3.2 5.9 5.3 3.8
Doxepin 3.2 4.8 3.8 3.6
Nordoxepin 4.2 6.5 4.6 3.7
a) ñ calculated as the ratio of the drug peak area obtained by sample stacking (sample injecting time was lengthened till all peaks remained
baseline separated) and the drug peak area obtained by usual injection (we assumed 12 s as the injection time, which corresponded to a
hydrodynamically injected sample size, equivalent to 1% of capillary volume).
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Figure 2. Optimization of separation conditions of the drugs (1 ñ Des, 2 ñ Nort, 3. ñ Nordox, 4 ñ Imi, 5 ñ Dox, 6 ñ IS, and 7 ñ Ami) by
modification of the background electrolyte (50 mM CAPSO (pH 9.54) in methanol/water) composition: a. 30% (w/v) of methanol, b. 60%
(w/v) of methanol, and c. 60% (w/v) of methanol and 0.143 mM of KCl. The concentrations of the drugs were as follows: 240 ng (Des),
400 ng (Dox), 500 ng (Ami, Nort, Imi and Nordox) and 2000 ng (IS). EOF ñ methanol
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Preparation of drug standard solutions and serum
samples
Drug standard solutions were prepared in ace-
tonitrile or in a mixture of 0.01% H3PO4 and
methanol (1:1, v/v) by adding the drug stock solu-
tions to obtain concentration of 20 µg/mL in appro-
priate medium.
Lyophilized reference serum was prepared for
analysis according to the procedure given by the
manufacturer. After reconstitution, three (1ñ3)
serum samples (0.5 mL) were pipetted and prepared
in the following way: sample 1 remained untouched,
sample 2 and 3 were spiked with standard drugs,
respectively doubling and triplicating in drug con-
centration compared to the certificated concentra-
tions in the reference material. For estimation of the
detection limits of the analytes examined, the con-
trol serum samples were spiked with appropriate
amounts of the drugs tested. 
All samples were subjected to liquid-liquid
extraction according to the following procedure.
First, all samples were diluted with water (1:1, v/v)
and spiked with the internal standard (2 µg of
clomipramine). To each sample, 3 mL of 0.6 M
NaOH and then 5 mL of n-hexane with isoamyl
alcohol (99:1, v/v) were added and mixed. Then, the
whole content was agitated for 10 min and cen-
trifuged (4000 rpm) for 10 min. The organic layer (4
mL) was transferred successively into a 0.5 mL con-
ical tube, and evaporated in a nitrogen stream mild-
ly heated to 42OC. The residue was dissolved with
120 µL of the extracting mixture (n-hexane/isoamyl
alcohol, 99:1; v/v) and vortexed for 0.5 min. The
analytes were then re-extracted into 25 µL of 0.01%
H3PO4. Twenty µL of the aqueous layer was mixed
with 20 µL of methanol, and injected into the capil-
lary.
Measurement procedure
A new capillary was conditioned by flushing
with 1 M NaOH (30 min), 0.5 M NaOH (5 min),
deionized water (5 min) and the background elec-
trolyte (15 min) in sequence. The measurement pro-
cedure consisted of three main steps: 1) washing the
capillary with freshly prepared background elec-
trolyte (2 min), 2) sample injection in hydrodynam-
ic (50 mbar) or electrokinetic mode (5 kV) from 12
to 96 s, and 3) separation of analytes under 30 kV.
Between measurements the capillary was purged
using the following sequence of reagents: 0.5 M
NaOH (2 min), water (3 min) and the background
electrolyte (3 min). 
RESULTS AND DISCUSSION
This study covered the most important classic
antidepressants including their metabolites: ami-
triptyline, nortriptyline, imipramine, desipramine,
doxepin and nordoxepin. Clomipramine, a drug
from the same pharmaceutical group, was chosen as
the internal standard.
The enhancement in the sensitivity of CE
analysis was achieved by use of stacking conditions,
i.e., a standard drug mixture was dissolved in a low
conductivity medium (acetonitrile or mixture 0.01%
H3PO4/methanol, 1:1, v/v) and then injected hydro-
dynamically or electrokinetically into the capillary.
Enhancement (stacking) factors, for all examined
Table 2. Optimization of the background electrolyte (50 mM CAPSO (pH 9.54) in methanol/water with salt addition) composition.
MeOH/water Salt Salt concentration RaPoint No.
(%, w/v)  cation (mM) (n = 3)
0 30 ñb 0 7.19
1 30 Na 0.143 8.21
2 30 Na 0.072 8.17
3 30 K 0.072 7.74
4 30 K 0.143 8.17
5 60 Na 0.143 8.77
6 60 Na 0.072 8.29
7 60 K 0.072 8.64
8 60 K 0.143 9.00
9 60 ñb 0 7.73
a) the global sum of peak resolutions was calculated as the median from three repeated measurements (in calculations, peak areas were
taken into account). b) no salt was added.
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drugs were calculated by dividing the drug peak
areas obtained by means of sample stacking (sample
injecting time was lengthened from 24 to 96 s till all
peaks remained baseline separated) and by usual
injection (we assumed 12 s as the initial injection
time, as it corresponds to the hydrodynamically
injected sample size equivalent to 1% of the capil-
lary volume). The best stacking conditions (the
highest values of enhancement factors) for the stan-
dard drug solutions were: hydrodynamic injection
mode and sample medium ñ mixture of 0.01%
H3PO4 and methanol (1:1, v/v) (Table 1).
In order to improve the separation efficiency of
the drugs, the initial composition of the background
electrolyte was optimized taking into account three
factors: 1. ratio of methanol to water in the back-
ground electrolyte, 2. kind of salt cation (Na+ or K+)
added to the electrolyte, 3. concentration of salt
added to this electrolyte. Each factor was examined
on two value levels and the analyses were performed
according to a 32 factorial design. As the optimum
criterion, the global sum of peaks resolutions (R)
between all adjacent drugs (iñj), including internal
standard were selected. A significant increase in res-
olution was predicted after some preliminary
research, thus the injection time was prolonged to 1
min. 
R = Σ Ri-j
where:
tj ñ tiRiñj = 2 ñññññññññwi + wj
ti and wi ñ retention time and peak width of peak I;
tj and wj ñ retention time and peak width of peak j;
If Ri-j = 1.5 then Ri-j was assumed to be 1.5. 
At optimal conditions, the response R should
be a maximum one. On the basis of the results
obtained from the experiments, the following com-
position of the separation electrolyte was chosen as
the optimum one (Table 2; experimental point N 8,
response R = 9.00): 0.143 mM KCl in
methanol/water (60:40; w/v). The protonation
degree of the drugs was lowered by increasing the
amount of methanol in the background electrolyte,
but there was only a little improvement in separation
of two desmethyl amine compounds (nortriptyline
and nordoxepin), however, the rest of the tested
drugs were not baseline separated (compare Figs. 2a
and 2b). The substantial improvement of separation
efficiency was achieved by addition of KCl salt into
the background electrolyte. This was caused by
adsorption ability of cation K+ on the capillary sur-
face, which resulted in reduction of the electroos-
motic flow and also by increasing the electric field
(15) (Fig. 2c). 
Comparing the findings in the performed
examinations with the results obtained by other
authors, it may be stated that the developed method
requires comparable (14) or even smaller amounts
of the examined body fluid (13) (taking into account
requirement of at least two samples analysis). The
sample preparation method used by Galeano-Diaz et
al. (14) was simpler (only enrichment of a serum
sample with sodium chloride and then precipitation
with acetonitrile was required) and CE measurement
was faster (ca. 6 min) but not all examined drugs
were completely separated and for lowering detec-
tion limits appropriate bubble shape cell (bubble
capillary) was required. The detection limits in the
proposed procedure are higher than those reported in
(13, 14) but they are low enough to apply this
method for determination of the studied drugs in
human serum at therapeutic concentrations.
Table 3. Validation parameters of the developed CE method.
Repeatability of
(TMD/TMIS)a (AD/ AIS)b Limit of Linearity AccuracyDrug 
[RSD, %] [RSD, %]  
detection correlation
RE [%]
C1c C2d C1c C2d
[ng/mL] coefficient (r2)
Amitriptyline 0.24 0.05 2.31 5.38 50.0 0.999 4.0
Nortriptyline 1.04 1.74 1.03 4.32 62.5 0.980 4.0
Imipramine 0.24 0.55 1.96 6.70 50.0 0.999 4.4
Desipramine 1.11 1.90 0.76 1.19 30.0 0.975 5.1
Doxepin 0.36 0.20 0.78 4.76 50.0 0.999 4.1
Nordoxepin 1.16 1.65 0.73 1.10 50.0 0.979 4.4
a) ñ ratio of the examined drug migration time and the internal standard migration time. b ñ ratio of the examined drug peak area and the
internal standard peak area. c ñ lower concentration drug level (120, 200 and 250 ng/mL for desipramine, doxepin and the rest of examined
drugs, respectively). d ñ higher concentration drug level (360, 600 and 750 ng/mL for desipramine, doxepin and the rest of examined drugs,
respectively).
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For validation of the analytical procedure, sev-
eral analytical parameters of the developed method
were determined. The precision was assessed by
four times repeated analyses of serum specimens
containing known concentrations (two concentra-
tion levels, Table 3) of the drugs investigated. By
these means, the repeatability of both qualitative
(relative migration time) and quantitative (relative
peak area) parameters were estimated. The detection
limits (LODs) for all drugs tested in the serum were
determined by estimation of the minimum concen-
tration equivalent to five times of the background
noise signal. The linearity of the method was stud-
ied for each examined drug in serum samples in the
following concentration ranges: 120ñ360 ng/mL for
desipramine, 200ñ600 ng/mL for doxepin and nor-
doxepin, and 250ñ750 ng/mL for amitriptyline, nor-
triptyline and imipramine, and the correlation coef-
ficient (r2) was calculated on the basis of three con-
centrations (points) for each drug. The accuracy of
the method was calculated as the relative error RE =
[(desired value ñ obtained value) /desired value] ◊
100%. The obtained values of the analytical param-
eters are presented in Table 3. 
CONCLUSIONS
A simple and sensitive CE screening method
for six tricyclic psychotropic drugs in human serum
has been developed. An experimental design (32 fac-
torial) was used to find optimal composition of the
separation electrolyte. As the optimum criterion, the
global sum of peaks resolutions (R) between all
adjacent drugs (iñj), including the internal standard
has been selected. In order to calibrate the proposed
analytical procedure, the standard addition method
was used instead of the method of the set of stan-
dards, which is commonly used in analysis of bio-
logical fluids for drug determination. The reason for
choosing the standard addition method was that this
method (in contrast to the latter one) was hoped to
compensate the matrix effects, which could be
expected in the case of analysis of biological mate-
rial, especially in the case of decomposed forensic
samples. 
The combination of sample preconcentration in
the capillary with a three point standard addition
method enables analysis of relatively small volumes
of (3 ◊ 0.5 mL) serum samples, containing the
examined drugs at therapeutic concentration levels.
The proposed CE procedure may be an alternative
for the chromatographic methods commonly used
for examination of these antidepressants in clinical
and forensic laboratories.
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